News & Media
The South American alpaca may seem like an unlikely ally in humanity’s fight to overcome the coronavirus, but an Irish scientist believes the mammal is key to developing an effective treatment against the disease.
Scientists at the Africa Health Research Institute (AHRI) in Durban, South Africa have now tested antibodies developed by Cape Town biotech company, Afrobodies, against the live virus SARS-CoV-2 variant 501Y.V2, also known as the ‘SA variant’.
Having previously established that antibodies produced by South African biotech company, Afrobodies, can stop the Covid-19 virus from infecting human cells, scientists at the MRC-University of Glasgow Centre for Virus Research (CVR) have taken their validation a step further.
A South African biotech company has produced antibodies that can prevent Covid-19 from infecting human cells. The antibodies were produced by an alpaca, a llama-like animal originating in South America…
Alpaca antibodies developed by Cape Town biotech company Afrobodies protect human cells from Covid-19 infection
Independent tests by a leading UK university have confirmed that antibodies produced by South African biotech company, Afrobodies, can stop the Covid-19 virus from infecting human cells.
Innovative entrepreneurs took centre stage when the winners of the 2018 Technology Innovation Agency’s Global Cleantech Innovation Programme of South Africa (GCIP-SA) were announced at a recent gala event in Cape Town.